Skip to content

An evaluation of Croí MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior diabetes in pregnancy

A randomised controlled trial of Croí MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior gestational diabetes mellitus (GDM)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN41202110
Enrollment
114
Registered
2012-05-28
Start date
2012-05-31
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus Pregnancy and Childbirth Diabetes mellitus in pregnancy, unspecified

Interventions

The control group will receive usual health care, which includes written information on diet and lifestyle changes recommended for reducing the risk of developing type 2 diabetes and visits with gener

Sponsors

Health Research Board (Ireland)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women of child-bearing age with a history of gestational diabetes mellitus. At recruitment, participants must also have the following risk factors for diabetes: either: 1. Impaired fasting glucose (FPG>5.67.8 130/80 mmHg 2.2. Total cholesterol > 4.5 mmol/l 2.3. Low density lipoprotein (LDL) cholesterol > 2.5 mmol/l 2.4. Triglycerides >1.69mmol/L 2.5. High density lipoprotein (HDL) cholesterol 30 2.7. Waist circumference > 88 cm

Exclusion criteria

Exclusion criteria: 1. Individuals with significant cognitive impairments or mental illness 2. Individuals with inadequate English language ability to understand the content of the intervention programme 3. Pregnant women

Design outcomes

Primary

MeasureTime frame
Glucose dysfunction, measured as mean reduction from baseline to 1-year follow-up by a Fasting Plasma Glucose (FPG) test and 2-hour postprandial (PP) glucose levels on a 75 g Oral Glucose Tolerance Test (OGTT).

Secondary

MeasureTime frame
1. Insulin resistance - decrease measured by HOMA analysis on insulin and glucose values on a 75 g OGTT 2. Diet adherence - measured as a combination of: 2.1. Mean improvement on the MedDietScore 2.2. Proportions achieving target fruit and vegetable consumption of >400 g/day; and 2.3. Proportions achieving oily fish intake of > once per week 3. Weight and shape - measured as: 3.1. Mean weight reduction (kg) in individuals with a Body Mass Index (BMI) of >30 kg/m2 at baseline; and 3.2. Mean reduction in waist circumference in individuals with >88 cm at baseline 4. Physical activity - measured as change in functional capacity on objective physical fitness test: Chester Step Test (CST) or 6-minute walk test 5. Lipid profile - measured as a combination of: 5.1. Proportions achieving a lipid target of total cholesterol 1.29 mmol/L; and 5.2. Mean reduction in total and LDL-cholesterol 6. Positive mental health - measured on 9-items related to energy and vitality during the past month, and non-specific psychological distress (from SLÁN, the National Survey of Health and Lifestyles in Ireland, 2007) 7. General health - measured on 1-item from SLÁN, the National Survey of Health and Lifestyles in Ireland, 2007 8. Quality of life - measured on 1-item from SLÁN, the National Survey of Health and Lifestyles in Ireland, 2007 9. Motivation to change - measured on 1-item assessing preparedness and motivation to change health-related behaviours (from the Stages of Change Model by Prochaska, DiClemente and Norcross, 1992) 10. Perceived social support - measured on 2-items from Moore et al.?s research on lifestyle intervention for type 2 diabetes (2007, 2009, 2011) 11. Diabetes-related self-efficacy - measured on a 2-part exercise on confidence to engage in exercise and healthy eating under different ?barrier? conditions (from Stanford University Patient Education Research Centre Self-efficacy for Diabetes Scale and Diabetes Empowerment Scale - Anderson, Funnell, Fitzgerald, &

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026